CRAI
CRA International, Inc. [CRAI] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CRAI Stock Summary
Top 10 Correlated ETFs
CRAI
Top 10 Correlated Stocks
CRAI
In the News
CRAI Financial details
CRAI Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-30
| Metric | History | 2019-12-28 | 2021-01-02 | 2022-01-01 | 2022-12-31 | 2023-12-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 57.38 | 65.44 | 76.24 | 81.86 | 89.04 | |
| Net income per share | 2.64 | 3.15 | 5.61 | 6.04 | 5.49 | |
| Operating cash flow per share | 3.54 | 7.04 | 10.2 | 3.48 | 8.57 | |
| Free cash flow per share | 1.42 | 4.84 | 9.84 | 2.95 | 8.23 | |
| Cash per share | 3.26 | 5.88 | 8.91 | 4.36 | 6.5 | |
| Book value per share | 25.14 | 26.91 | 27.73 | 29.25 | 30.27 | |
| Tangible book value per share | 13.07 | 14.77 | 15.18 | 15.19 | 15.83 | |
| Share holders equity per share | 25.14 | 26.91 | 27.73 | 29.25 | 30.27 | |
| Interest debt per share | 20.42 | 19.85 | 18.83 | 17.15 | 16.06 | |
| Market cap | 421.38M | 395.62M | 693.01M | 883.7M | 692.74M | |
| Enterprise value | 555.14M | 502.95M | 765.68M | 974.23M | 755.91M | |
| P/E ratio | 20.31 | 16.14 | 16.63 | 20.26 | 18 | |
| Price to sales ratio | 0.93 | 0.78 | 1.22 | 1.5 | 1.11 | |
| POCF ratio | 15.14 | 7.24 | 9.15 | 35.18 | 11.53 | |
| PFCF ratio | 37.83 | 10.53 | 9.48 | 41.47 | 12 | |
| P/B Ratio | 2.13 | 1.89 | 3.37 | 4.19 | 3.27 | |
| PTB ratio | 2.13 | 1.89 | 3.37 | 4.19 | 3.27 | |
| EV to sales | 1.23 | 0.99 | 1.35 | 1.65 | 1.21 | |
| Enterprise value over EBITDA | 13.88 | 10.56 | 11.18 | 13.77 | 9.17 | |
| EV to operating cash flow | 19.95 | 9.2 | 10.11 | 38.78 | 12.58 | |
| EV to free cash flow | 49.84 | 13.39 | 10.48 | 45.72 | 13.1 | |
| Earnings yield | 0.05 | 0.06 | 0.06 | 0.05 | 0.06 | |
| Free cash flow yield | 0.03 | 0.09 | 0.11 | 0.02 | 0.08 | |
| Debt to equity | 0.81 | 0.73 | 0.67 | 0.58 | 0.51 | |
| Debt to assets | 0.3 | 0.27 | 0.25 | 0.22 | 0.2 | |
| Net debt to EBITDA | 3.34 | 2.25 | 1.06 | 1.28 | 0.77 | |
| Current ratio | 1.07 | 1.1 | 1.17 | 1.15 | 1.12 | |
| Interest coverage | 23.4 | 28.62 | 57.46 | 32.17 | 14.85 | |
| Income quality | 1.34 | 2.23 | 1.82 | 0.58 | 1.57 | |
| Dividend Yield | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | |
| Payout ratio | 0.32 | 0.3 | 0.2 | 0.22 | 0.28 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.18 | 0.17 | 0.17 | 0.18 | 0.18 | |
| Capex to operating cash flow | -0.6 | -0.31 | -0.03 | -0.15 | -0.04 | |
| Capex to revenue | -0.04 | -0.03 | 0 | -0.01 | 0 | |
| Capex to depreciation | -0.78 | -0.69 | -0.1 | -0.15 | -0.09 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Graham number | 38.63 | 43.7 | 59.19 | 63.07 | 61.15 | |
| ROIC | 0.04 | 0.05 | 0.09 | 0.1 | 0.1 | |
| Return on tangible assets | 0.05 | 0.05 | 0.09 | 0.1 | 0.09 | |
| Graham Net | -25.62 | -24.39 | -21.8 | -22.45 | -19.88 | |
| Working capital | 12.67M | 19.84M | 36.26M | 31.74M | 29.39M | |
| Tangible asset value | 102.77M | 114.72M | 112.72M | 109.64M | 110.92M | |
| Net current asset value | -151.42M | -129.52M | -100.18M | -90.9M | -75.63M | |
| Invested capital | 0.81 | 0.73 | 0.67 | 0.58 | 0.51 | |
| Average receivables | 137.5M | 148.44M | 157.27M | 178.52M | 201.65M | |
| Average payables | 24M | 22.75M | 21.47M | 25.55M | 28.14M | |
| Average inventory | 0.5 | 0.5 | 0.5 | 0.5 | 0 | |
| Days sales outstanding | 116.78 | 109.47 | 104.52 | 120.44 | 121.86 | |
| Days payables outstanding | 29.94 | 19.13 | 21.45 | 24.55 | 23.16 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 3.13 | 3.33 | 3.49 | 3.03 | 3 | |
| Payables turnover | 12.19 | 19.08 | 17.02 | 14.87 | 15.76 | |
| Inventory turnover | 317.76M | 0 | 400.05M | 0 | 0 | |
| ROE | 0.1 | 0.12 | 0.2 | 0.21 | 0.18 | |
| Capex per share | -2.12 | -2.2 | -0.35 | -0.53 | -0.34 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-30 for Q4
| Metric | History | 2022-12-31 | 2023-04-01 | 2023-07-01 | 2023-09-30 | 2023-12-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 20.34 | 21.47 | 23.19 | 21.15 | 23.24 | |
| Net income per share | 1.22 | 1.25 | 1.36 | 1.23 | 1.65 | |
| Operating cash flow per share | 8.44 | -9.84 | 0.73 | 9.31 | 8.64 | |
| Free cash flow per share | 8.32 | -9.92 | 0.62 | 9.21 | 8.59 | |
| Cash per share | 4.41 | 4.99 | 2.04 | 12.22 | 6.56 | |
| Book value per share | 29.62 | 27.64 | 29.04 | 29.81 | 30.5 | |
| Tangible book value per share | 15.38 | 13.34 | 14.46 | 15.33 | 15.95 | |
| Share holders equity per share | 29.62 | 27.64 | 29.04 | 29.81 | 30.5 | |
| Interest debt per share | 17.18 | 30.71 | 28.06 | 20.73 | 15.73 | |
| Market cap | 872.8M | 767.57M | 712.27M | 703M | 687.4M | |
| Enterprise value | 963.34M | 950.14M | 892.32M | 819M | 750.57M | |
| P/E ratio | 25.16 | 21.52 | 18.73 | 20.45 | 15 | |
| Price to sales ratio | 6.02 | 5.02 | 4.4 | 4.76 | 4.25 | |
| POCF ratio | 14.51 | -10.96 | 140.43 | 10.82 | 11.44 | |
| PFCF ratio | 14.71 | -10.87 | 163.66 | 10.95 | 11.51 | |
| P/B Ratio | 4.13 | 3.9 | 3.51 | 3.38 | 3.24 | |
| PTB ratio | 4.13 | 3.9 | 3.51 | 3.38 | 3.24 | |
| EV to sales | 6.64 | 6.22 | 5.51 | 5.55 | 4.64 | |
| Enterprise value over EBITDA | 59.33 | 47.02 | 47.5 | 59.61 | 31.78 | |
| EV to operating cash flow | 16.02 | -13.56 | 175.93 | 12.61 | 12.49 | |
| EV to free cash flow | 16.24 | -13.46 | 205.04 | 12.75 | 12.56 | |
| Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
| Free cash flow yield | 0.07 | -0.09 | 0.01 | 0.09 | 0.09 | |
| Debt to equity | 0.58 | 1.11 | 0.96 | 0.69 | 0.51 | |
| Debt to assets | 0.22 | 0.39 | 0.35 | 0.27 | 0.2 | |
| Net debt to EBITDA | 5.58 | 9.04 | 9.58 | 8.44 | 2.67 | |
| Current ratio | 1.15 | 1.02 | 1.07 | 1.11 | 1.12 | |
| Interest coverage | 27.48 | 23.98 | 9.85 | 10.53 | 28.58 | |
| Income quality | 6.93 | -7.86 | 0.53 | 7.56 | 5.26 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0.31 | 0.3 | 0.27 | 0.3 | 0.26 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.18 | 0.18 | 0.18 | 0.19 | 0.18 | |
| Capex to operating cash flow | -0.01 | 0.01 | -0.14 | -0.01 | -0.01 | |
| Capex to revenue | -0.01 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -0.13 | -0.09 | -0.11 | -0.11 | -0.06 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Graham number | 28.47 | 27.91 | 29.83 | 28.74 | 33.63 | |
| ROIC | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | |
| Return on tangible assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | |
| Graham Net | -22.73 | -24.09 | -24.94 | -14.46 | -20.03 | |
| Working capital | 31.74M | 4.51M | 15.73M | 24.45M | 29.39M | |
| Tangible asset value | 109.64M | 94.98M | 101M | 106.95M | 110.92M | |
| Net current asset value | -90.9M | -106.99M | -93.55M | -82.39M | -75.63M | |
| Invested capital | 0.58 | 1.11 | 0.96 | 0.69 | 0.51 | |
| Average receivables | 207.15M | 203M | 212.05M | 203.21M | 200.82M | |
| Average payables | 26.99M | 25.22M | 22.88M | 23.81M | 26.71M | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 121.05 | 124.25 | 118.41 | 117.92 | 116.01 | |
| Days payables outstanding | 24.66 | 19.07 | 18.19 | 21 | 22.37 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0.74 | 0.72 | 0.76 | 0.76 | 0.78 | |
| Payables turnover | 3.65 | 4.72 | 4.95 | 4.29 | 4.02 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.04 | 0.05 | 0.05 | 0.04 | 0.05 | |
| Capex per share | -0.11 | -0.08 | -0.1 | -0.1 | -0.05 |
CRAI Frequently Asked Questions
What is CRA International, Inc. stock symbol ?
CRA International, Inc. is a US stock , located in Boston of Ma and trading under the symbol CRAI
What is CRA International, Inc. stock quote today ?
CRA International, Inc. stock price is $145.36 today.
Is CRA International, Inc. stock public?
Yes, CRA International, Inc. is a publicly traded company.
Company Profile
- Volume Average 31.42K
- Market Capitalization 999M
- Employee 1K
- CEO Mr. Paul A. Maleh
- Headquarters Boston,MA,US
- IPO Date 1998-04-24
-
Website
https://www.crai.com 
CRA International, Inc., together with its subsidiaries, provides economic, financial, and management consulting services in the United States, the United Kingdom, and internationally. It advises clients on economic and financial matters pertaining to litigation and regulatory proceedings; and guides corporations through business strategy and performance-related issues. The company also offers consulting services, including research and analysis, expert testimony, and support in litigation and regulatory proceedings in the areas of finance, accounting, economics, insurance, and forensic accounting and investigations to corporate clients and attorneys. In addition, it offers management consulting services comprising strategy development, performance improvement, corporate strategy and portfolio analysis, estimation of market demand, new product pricing strategies, valuation of intellectual property and other assets, assessment of competitors' actions, and analysis of new sources of supply. The company serves various industries, including communications and media; consumer, health, and wellness products; energy; entertainment and leisure; financial services; healthcare; life sciences; manufacturing and industries; natural resources; retail and distribution; technology; and transportation. CRA International, Inc. was incorporated in 1965 and is headquartered in Boston, Massachusetts.
